Miralax and International normalised ratio increased - a phase IV clinical study of FDA data
Summary:
International normalised ratio increased is reported as a side effect among people who take Miralax (polyethylene glycol 3350), especially for people who are male, 60+ old, also take Coumadin, and have Atrial fibrillation/flutter.
The phase IV clinical study analyzes which people have International normalised ratio increased when taking Miralax. It is created by eHealthMe based on reports of 80,819 people who have side effects when taking Miralax from the FDA, and is updated regularly.
What is Miralax?
Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.
What is International normalised ratio increased?
International normalised ratio increased is found to be associated with 1,333 drugs and 1,727 conditions by eHealthMe. Check the latest studies of International normalised ratio increased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
80,819 people reported to have side effects when taking Miralax.
Among them, 163 people (0.2%) have International normalised ratio increased.
Among these 163 people:
What is the gender of people who have International normalised ratio increased when taking Miralax? *
What is the age of people who have International normalised ratio increased when taking Miralax? *
What are other drugs people take besides Miralax? *
What are other side effects people have besides International normalised ratio increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Miralax and have International normalised ratio increased?
- Check whether International normalised ratio increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Miralax:
- Miralax (81,754 reports)
International normalised ratio increased treatments and more:
- International normalised ratio increased (40,071 reports)
How severe was International normalised ratio increased and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Miralax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with International normalised ratio increased:
- International normalised ratio increased (1,333 drugs)
Browse all the conditions that are associated with International normalised ratio increased:
- International normalised ratio increased (1,727 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acromegaly and Ear Disorder - 5 seconds ago
- Could Remicade cause Chronic Obstructive Pulmonary Disease? - 6 seconds ago
- Amlodipine vs. Lotensin Hct, side effect and effectiveness comparison - 7 seconds ago
- Sedation and Gait Disturbance - 8 seconds ago
- Morphine Sulfate vs. Tramadol Hydrochloride And Acetaminophen, side effect and effectiveness comparison - 9 seconds ago
- Drug interactions of Linzess and Ritalin - 9 seconds ago
- Seasonal Allergy and Aggression - 10 seconds ago
- Could Remeron cause Osteolysis? - 10 seconds ago
- Could Remeron cause Therapeutic Response Unexpected? - 13 seconds ago
- Methergine vs. Ibu, side effect and effectiveness comparison - 15 seconds ago